LifeSplice Pharma (United States)
- Research works
- 0 ▼ 100% vs 2013–17
- Citations
- 2 6.1 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 100% world 28%
Not ranked overall: LifeSplice Pharma (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does LifeSplice Pharma (United States) publish most on?
By volume: RNA and protein synthesis mechanisms, RNA regulation and disease and Neuroscience and Neuropharmacology Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 RNA and protein synthesis mechanisms Molecular Biology 0 works
- 2 RNA regulation and disease Molecular Biology 0 works
- 3 Neuroscience and Neuropharmacology Research Cellular and Molecular Neuroscience 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
Other research institutions in Malvern
- Siemens Healthcare (United States)
- Endo Pharmaceuticals (United States)
- Immaculata University
- Ricoh (United States)
- Reaction Biology Corporation (United States)
- Applied Pulsed Power (United States)
- TetraLogic Pharmaceuticals (United States)
- Saint-Gobain (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.